Stay updated with breaking news from Eric Elenko. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Shares of Karuna Therapeutics, Inc. (NASDAQ:KRTX – Get Rating) have earned an average rating of “Buy” from the twelve ratings firms that are currently covering the firm, MarketBeat Ratings reports. One research analyst has rated the stock with a hold recommendation and eleven have assigned a buy recommendation to the company. The average 12 month […]
Read the latest stock market news on MarketBeat. Get real-time analyst ratings, dividend information, earnings results, financials, headlines, insider trades and options data for any stock.
Wall Street brokerages forecast that Karuna Therapeutics, Inc. (NASDAQ:KRTX – Get Rating) will post ($2.01) earnings per share for the current fiscal quarter, Zacks reports. Zero analysts have provided estimates for Karuna Therapeutics’ earnings, with the highest EPS estimate coming in at ($1.64) and the lowest estimate coming in at ($2.52). Karuna Therapeutics reported earnings […]
Investegate announcements from PureTech Health PLC, PRTC's Gelesis to Debut on NYSE Today Ticker GLS